Doximity(DOCS)
Search documents
Doximity (DOCS) Beats Stock Market Upswing: What Investors Need to Know
ZACKS· 2025-03-21 23:20
Company Performance - Doximity (DOCS) closed at $62.99, with a +0.35% change from the previous day's closing price, outperforming the S&P 500 which gained 0.08% [1] - Over the past month, Doximity's shares have decreased by 16.31%, while the Medical sector and S&P 500 have lost 1.03% and 7.33% respectively [1] Upcoming Earnings - Analysts expect Doximity to report an EPS of $0.27, reflecting an 8% increase year-over-year, with projected revenue of $133.76 million, up 13.3% from the same quarter last year [2] - For the annual period, earnings are anticipated to be $1.31 per share and revenue at $562.98 million, indicating increases of +37.89% and +18.42% respectively from the previous year [3] Analyst Sentiment - Recent revisions in analyst estimates suggest optimism regarding Doximity's business and profitability, with a 1.52% increase in the Zacks Consensus EPS estimate over the last 30 days [3][5] - Doximity currently holds a Zacks Rank of 1 (Strong Buy), which has historically provided an average annual return of +25% since 1988 [5] Valuation Metrics - Doximity's Forward P/E ratio stands at 47.99, significantly higher than the industry's Forward P/E of 16.32, indicating a premium valuation [6] - The company's PEG ratio is currently 2.6, compared to the average PEG ratio of 1.43 for Medical Services stocks [6] Industry Context - The Medical Services industry, part of the broader Medical sector, holds a Zacks Industry Rank of 75, placing it in the top 30% of over 250 industries [7] - Research indicates that industries in the top 50% outperform those in the bottom half by a factor of 2 to 1 [7]
Buy These 5 Top-Ranked Stocks to Play Likely Earnings Beat
ZACKS· 2025-03-12 13:25
Core Insights - Investors seek stocks that can outperform market expectations ahead of earnings season, focusing on high-quality stocks [1] - Positive earnings surprises are crucial as stocks often decline if they miss or merely meet expectations, regardless of nominal earnings growth [2][3] - A significant earnings surprise can lead to a substantial increase in stock price immediately after the earnings release [4] Stock Selection Criteria - Stocks with a last EPS surprise of at least 10% are more likely to surprise again [7] - An average EPS surprise of over 20% in the last four quarters indicates strong potential for future earnings beats [8] - A Zacks Rank of 1 (Strong Buy) or 2 (Buy) is required for stocks to be considered [8][9] - Positive Earnings ESP is necessary for a stock to achieve an earnings beat [9] - Long-term growth potential is assessed through estimated EPS growth of over 10% per year and an average trading volume exceeding 100,000 [10] Highlighted Stocks - **Doximity (DOCS)**: Zacks Rank 1, average earnings surprise of 26.00% over the past four quarters [11] - **Life Time Group Holdings (LTH)**: Zacks Rank 1, average earnings surprise of 21.58% [12] - **Adtalem Global Education (ATGE)**: Zacks Rank 1, average earnings surprise of 21.58% [13] - **BioMarin Pharmaceutical (BMRN)**: Zacks Rank 2, average earnings surprise of 32.36% [14] - **Iridium Communications (IRDM)**: Zacks Rank 2, average earnings surprise of 35.22% [14]
Buy 5 High-Flying Health & Fitness Stocks Year to Date With More Upside
ZACKS· 2025-03-07 14:50
Core Viewpoint - U.S. stock markets are experiencing significant volatility, primarily due to tariff and trade policies from the Trump administration, alongside signs of a softening economy [1][2] Industry Overview - The health and fitness industry is witnessing growing demand driven by increased global awareness of health issues and the importance of physical fitness, supported by rising lifestyle-related diseases and a focus on preventive healthcare [4] - The industry's growth is bolstered by diverse revenue streams, including subscriptions, product sales, and services, making it attractive for long-term investment [5] - Technological advancements, such as fitness trackers and wearable devices, are creating new growth opportunities and enhancing consumer engagement [5] Company Highlights - **Garmin Ltd. (GRMN)**: - Zacks Rank 1, benefiting from strong momentum in Fitness and Auto OEM segments, with a projected revenue CAGR of 9.3% from fiscal 2025-2027 [11][12] - Expected revenue and earnings growth rates of 9.7% and 8% for the current year, respectively [12] - **Sprouts Farmers Market Inc. (SFM)**: - Zacks Rank 1, focusing on product innovation and e-commerce, with net sales expected to rise between 10.5% and 12.5% in 2025 [13][14] - Expected revenue and earnings growth rates of 12.1% and 21.6% for the current year, respectively [15] - **Doximity Inc. (DOCS)**: - Zacks Rank 1, providing a digital platform for medical professionals, with expected revenue and earnings growth rates of 11.5% and 8.1% for the next year [16][17] - **Life Time Group Holdings Inc. (LTH)**: - Zacks Rank 1, offering a range of health and wellness experiences, with expected revenue and earnings growth rates of 12.9% and 36.8% for the current year [18][20] - **V.F. Corp. (VFC)**: - Zacks Rank 2, showing strong performance in revenues and earnings, with expected growth rates of 2.3% and 46.2% for the next year [21][23]
Is Doximity (DOCS) a Solid Growth Stock? 3 Reasons to Think "Yes"
ZACKS· 2025-02-28 18:50
Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying stocks that can fulfill their growth potential is challenging due to associated risks and volatility [1] Group 1: Company Overview - Doximity (DOCS) is highlighted as a recommended growth stock with a favorable Growth Score and a top Zacks Rank [2] - The company has a historical EPS growth rate of 17.5%, with projected EPS growth of 36% this year, significantly surpassing the industry average of 11% [4] - Doximity's year-over-year cash flow growth is 23.5%, compared to an industry average of -11.2% [5] - The company's annualized cash flow growth rate over the past 3-5 years is 66.7%, while the industry average is 13.4% [6] Group 2: Earnings and Estimates - Positive trends in earnings estimate revisions are crucial, with Doximity experiencing a 15.9% increase in current-year earnings estimates over the past month [8] - The combination of strong earnings growth, cash flow growth, and positive earnings estimate revisions has positioned Doximity as a Zacks Rank 1 stock and earned it a Growth Score of B [10]
Doximity: Rating Downgrade As Near-Term Upside Is Priced In
Seeking Alpha· 2025-02-14 22:53
Core Viewpoint - Doximity (NYSE: DOCS) is considered an attractive investment opportunity due to its potential for organic growth exceeding GDP growth over the next 5-10 years, sustainable competitive advantages, and fair valuation [1] Group 1: Investment Thesis - The company is positioned in a sector expected to experience structural growth [1] - Doximity's profits are derived from sustainable competitive advantages that lead to attractive unit economics [1] - The management is characterized as competent, ethical, and long-term focused [1]
Doximity Momentum, Big Money Support Stays Strong
FX Empire· 2025-02-14 12:49
Core Viewpoint - The content emphasizes the importance of conducting personal due diligence and consulting competent advisors before making any financial decisions, particularly in the context of investments and trading [1]. Group 1 - The website provides general news, personal analysis, and third-party content intended for educational and research purposes [1]. - It explicitly states that the information does not constitute any recommendation or advice for investment actions [1]. - Users are advised to perform their own research and consider their financial situation before making decisions [1]. Group 2 - The website includes information about complex financial instruments such as cryptocurrencies and contracts for difference (CFDs), which carry a high risk of losing money [1]. - It encourages users to understand how these instruments work and the associated risks before investing [1].
Doximity (DOCS) is an Incredible Growth Stock: 3 Reasons Why
ZACKS· 2025-02-12 18:46
Core Viewpoint - Growth stocks are appealing due to their above-average financial growth, but identifying the right ones can be challenging due to associated risks and volatility [1] Group 1: Company Overview - Doximity (DOCS) is highlighted as a recommended growth stock, possessing a favorable Growth Score and a top Zacks Rank [2] - The company operates in the medical social networking sector, which is currently experiencing significant growth potential [3] Group 2: Earnings Growth - Doximity has a historical EPS growth rate of 17.5%, with projected EPS growth of 32.6% for the current year, significantly surpassing the industry average of 11.5% [4] Group 3: Cash Flow Growth - The year-over-year cash flow growth for Doximity stands at 23.5%, compared to an industry average of -12.1%, indicating strong financial health [5] - Over the past 3-5 years, Doximity's annualized cash flow growth rate has been 66.7%, while the industry average is 13.6% [6] Group 4: Earnings Estimate Revisions - There has been a positive trend in earnings estimate revisions for Doximity, with the Zacks Consensus Estimate for the current year increasing by 12.2% over the past month [7] Group 5: Investment Potential - Doximity's combination of a Zacks Rank 1 and a Growth Score of B suggests it is a potential outperformer and a solid choice for growth investors [9]
Why Doximity (DOCS) Might be Well Poised for a Surge
ZACKS· 2025-02-12 18:20
Core Viewpoint - Doximity (DOCS) shows a significantly improving earnings outlook, making it a strong investment choice as analysts continue to raise earnings estimates for the company [1][3]. Estimate Revisions - The rising trend in earnings estimate revisions reflects growing analyst optimism regarding Doximity's earnings prospects, which is expected to positively impact its stock price [2]. - For the current quarter, the earnings estimate is $0.26 per share, representing a +4% change from the previous year, with a 20.9% increase in the Zacks Consensus Estimate due to six upward revisions [4]. - For the full year, Doximity is expected to earn $1.26 per share, a +32.63% change from the prior year, with a 12.21% increase in the consensus estimate following seven upward revisions [5]. Zacks Rank - Doximity currently holds a Zacks Rank 1 (Strong Buy), indicating strong agreement among analysts in raising earnings estimates, which historically correlates with significant stock outperformance [6]. - Stocks with Zacks Rank 1 and 2 have shown to significantly outperform the S&P 500, suggesting a favorable investment environment for Doximity [6]. Stock Performance - Doximity's stock has increased by 47.6% over the past four weeks due to strong estimate revisions, indicating potential for further upside [7].
Doximity (DOCS) is a Great Momentum Stock: Should You Buy?
ZACKS· 2025-02-12 18:01
Group 1: Company Overview - Doximity (DOCS) currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 1 (Strong Buy), which is associated with a high likelihood of outperforming the market [3] Group 2: Price Performance - Over the past week, Doximity shares have increased by 34.06%, while the Zacks Medical Services industry has decreased by 0.55% [5] - In a longer time frame, Doximity's monthly price change is 47.61%, significantly outperforming the industry's 2.2% [5] - Over the last quarter, Doximity shares have risen by 45.43%, and they are up 158.24% over the past year, compared to the S&P 500's increases of 1.46% and 22.28%, respectively [6] Group 3: Trading Volume - Doximity's average 20-day trading volume is 2,393,111 shares, which serves as a bullish indicator when combined with rising stock prices [7] Group 4: Earnings Outlook - In the past two months, 7 earnings estimates for Doximity have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $1.13 to $1.26 [9] - For the next fiscal year, 7 estimates have also moved upwards without any downward revisions [9] Group 5: Conclusion - Considering the strong price performance, positive earnings outlook, and high momentum score, Doximity is positioned as a promising investment opportunity [11]
Doximity Q3 Earnings: Outpacing Even Management's Expectations
Seeking Alpha· 2025-02-10 17:04
Core Insights - Michael Dion is an expert in FP&A, Corporate Finance, and Small Business with 12 years of experience in Fortune 100 companies and various industries [1] - He founded F9 Finance to assist finance professionals and small business owners in understanding finance and accounting concepts [1] - Dion's investment strategy focuses on identifying value opportunities where market reactions to news are disproportionate, emphasizing strong fundamentals and dividends [1] Industry and Company Analysis - The finance experience spans multiple sectors including Telecom, Media and Entertainment, Hospitality, and Construction [1] - The approach to investment is influenced by both large corporations and small businesses, highlighting the importance of cash flow for companies and investors alike [1]